Greater efficacy of chemotherapy plus bevacizumab compared to chemo- and targeted therapy alone on non-small cell lung cancer patients with brain metastasis

類似資料

• Comparison of bevacizumab plus chemotherapy with chemotherapy alone in advanced non-small-lung cancer patients
  著者:: Tang, Ning, 等
  出版事項: (2016)
• Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis
  著者:: Botrel, Tobias Engel Ayer, 等
  出版事項: (2016)
• Efficacy and safety of bevacizumab plus erlotinib versus bevacizumab or erlotinib alone in the treatment of non-small-cell lung cancer: a systematic review and meta-analysis
  著者:: Zhang, Shu, 等
  出版事項: (2016)
• A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer
  著者:: Wang H, 等
  出版事項: (2020-05-01)
• Safety and Patient-Reported Outcomes of Atezolizumab Plus Chemotherapy With or Without Bevacizumab Versus Bevacizumab Plus Chemotherapy in Non–Small-Cell Lung Cancer
  著者:: Reck, Martin, 等
  出版事項: (2020)